Lifitegrast
Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist used for the treatment of dry eye disease.
Detailed technical, regulatory, and supply information is available for commercial evaluation.
Technical Overview
Lifitegrast – CAS 1085412-37-8
CAS Number
1085412-37-8
Category
Dry eye disease
Therapeutic Class
LFA-1 antagonist
Description
Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist used for the treatment of dry eye disease.
Applications
- Dry eye disease
- Ocular inflammation
Handling & Supply Details
Packaging
Standard export packaging in double-lined HDPE drums or fiber drums with inner poly liners; custom pack sizes available on request.
Product Inquiry
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer.